
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington’s and Parkinson’s Disease
Talita Glaser, Roberta Andrejew, Ágatha Oliveira‐Giacomelli, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 11, pp. 1299-1314
Open Access | Times Cited: 28
Talita Glaser, Roberta Andrejew, Ágatha Oliveira‐Giacomelli, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 11, pp. 1299-1314
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Novel targeted therapies for Parkinson’s disease
Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 78
Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 78
The barrier and interface mechanisms of the brain barrier, and brain drug delivery
Shanshan Zhang, Lin Gan, Fengye Cao, et al.
Brain Research Bulletin (2022) Vol. 190, pp. 69-83
Open Access | Times Cited: 56
Shanshan Zhang, Lin Gan, Fengye Cao, et al.
Brain Research Bulletin (2022) Vol. 190, pp. 69-83
Open Access | Times Cited: 56
Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases
Huiyong Zheng, Qiang Liu, Siwei Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Huiyong Zheng, Qiang Liu, Siwei Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Metabolic Aspects of Adenosine Functions in the Brain
Mercedes Garcia‐Gil, Marcella Camici, S. Allegrini, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 49
Mercedes Garcia‐Gil, Marcella Camici, S. Allegrini, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 49
Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS
Yafei Zhao, Yong Tang, Péter Illés
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 47
Yafei Zhao, Yong Tang, Péter Illés
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 47
Purinergic receptors in cognitive disturbances
Péter Illés, Henning Ulrich, Jiang‐Fan Chen, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106229-106229
Open Access | Times Cited: 16
Péter Illés, Henning Ulrich, Jiang‐Fan Chen, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106229-106229
Open Access | Times Cited: 16
Effects of Magnetite Nanoparticles and Static Magnetic Field on Neural Differentiation of Pluripotent Stem Cells
Ana Semeano, Fabiano Tófoli de Araújo, Juliana Corrêa-Velloso, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 4, pp. 1337-1354
Closed Access | Times Cited: 24
Ana Semeano, Fabiano Tófoli de Araújo, Juliana Corrêa-Velloso, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 4, pp. 1337-1354
Closed Access | Times Cited: 24
Purinergic signaling: a potential therapeutic target for depression and chronic pain
Yuting Zou, Runan Yang, Lin Li, et al.
Purinergic Signalling (2021) Vol. 19, Iss. 1, pp. 163-172
Open Access | Times Cited: 29
Yuting Zou, Runan Yang, Lin Li, et al.
Purinergic Signalling (2021) Vol. 19, Iss. 1, pp. 163-172
Open Access | Times Cited: 29
A Novel and Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions
Shima Kouhnavardi, Alev Ecevitoglu, Vladimir Dragačević, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 881-881
Open Access | Times Cited: 18
Shima Kouhnavardi, Alev Ecevitoglu, Vladimir Dragačević, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 881-881
Open Access | Times Cited: 18
Biological insights from the direct measurement of purine release
Nicholas Dale
Biochemical Pharmacology (2021) Vol. 187, pp. 114416-114416
Open Access | Times Cited: 21
Nicholas Dale
Biochemical Pharmacology (2021) Vol. 187, pp. 114416-114416
Open Access | Times Cited: 21
Purinergic Signaling in the Central Nervous System in Health and Disease
Péter Illés, Guang–Yin Xu, Yong Tang
Neuroscience Bulletin (2020) Vol. 36, Iss. 11, pp. 1239-1241
Open Access | Times Cited: 19
Péter Illés, Guang–Yin Xu, Yong Tang
Neuroscience Bulletin (2020) Vol. 36, Iss. 11, pp. 1239-1241
Open Access | Times Cited: 19
Purine Nucleotides Metabolism and Signaling in Huntington’s Disease: Search for a Target for Novel Therapies
Marta Tomczyk, Talita Glaser, Ewa M. Słomińska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6545-6545
Open Access | Times Cited: 17
Marta Tomczyk, Talita Glaser, Ewa M. Słomińska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6545-6545
Open Access | Times Cited: 17
A Possible Causal Involvement of Neuroinflammatory, Purinergic P2X7 Receptors in Psychiatric Disorders
Yong Tang, Péter Illés, Ying Zhang, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2142-2155
Open Access | Times Cited: 11
Yong Tang, Péter Illés, Ying Zhang, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2142-2155
Open Access | Times Cited: 11
Targeting GATA1 and p2x7r Locus Binding in Spinal Astrocytes Suppresses Chronic Visceral Pain by Promoting DNA Demethylation
Yanyan Wu, Hailong Zhang, Xiaomin Lu, et al.
Neuroscience Bulletin (2021) Vol. 38, Iss. 4, pp. 359-372
Open Access | Times Cited: 14
Yanyan Wu, Hailong Zhang, Xiaomin Lu, et al.
Neuroscience Bulletin (2021) Vol. 38, Iss. 4, pp. 359-372
Open Access | Times Cited: 14
Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson’s Disease
Chao Gu, Yajing Chen, Yan Chen, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
Chao Gu, Yajing Chen, Yan Chen, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
P2X7 receptors: a bibliometric review from 2002 to 2023
Haiting Tang, Wei Wei, Yu Luo, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1
Haiting Tang, Wei Wei, Yu Luo, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1
Implications of COVID-19 in Parkinson’s disease: the purinergic system in a therapeutic-target perspective to diminish neurodegeneration
Júlia Leão Batista Simões, Geórgia de Carvalho Braga, Samantha Webler Eichler, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 5, pp. 487-507
Closed Access | Times Cited: 1
Júlia Leão Batista Simões, Geórgia de Carvalho Braga, Samantha Webler Eichler, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 5, pp. 487-507
Closed Access | Times Cited: 1
Adenosine and adenosine receptors in metabolic imbalance-related neurological issues
Mi‐Hyeon Jang, Juhyun Song
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116996-116996
Open Access | Times Cited: 1
Mi‐Hyeon Jang, Juhyun Song
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116996-116996
Open Access | Times Cited: 1
Partners in health and disease: pineal gland and purinergic signalling
Regina P. Markus, Kassiano dos Santos Sousa, Henning Ulrich, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1
Regina P. Markus, Kassiano dos Santos Sousa, Henning Ulrich, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1
Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease
Stefanie Hagenow, Anna Affini, Elsa Y. Pioli, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8246-8262
Closed Access | Times Cited: 10
Stefanie Hagenow, Anna Affini, Elsa Y. Pioli, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8246-8262
Closed Access | Times Cited: 10
Glial Purinergic Signaling-Mediated Oxidative Stress (GPOS) in Neuropsychiatric Disorders
Lumei Huang, Yong Tang, Beáta Sperlágh
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 5
Lumei Huang, Yong Tang, Beáta Sperlágh
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 5
Antagonistic Roles of P2X7 and P2Y2 Receptors in Neurodegenerative Diseases
Talita Glaser, Ágatha Oliveira‐Giacomelli, Lyvia Lintzmaier Petiz, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 6
Talita Glaser, Ágatha Oliveira‐Giacomelli, Lyvia Lintzmaier Petiz, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 6
Arctiin Mitigates Neuronal Injury by Modulating the P2X7R/NLPR3 Inflammasome Signaling Pathway
Guang‐Nan Jin, Yu Wang, Yiming Liu, et al.
Inflammation (2024)
Closed Access
Guang‐Nan Jin, Yu Wang, Yiming Liu, et al.
Inflammation (2024)
Closed Access
Naturally Occurring Parkinson’s Disease Raises the Need for Nonhuman Primates in Neurodegenerative Diseases Research
Yuxuan Yao, Ji Dai
Neuroscience Bulletin (2021) Vol. 37, Iss. 8, pp. 1267-1269
Open Access | Times Cited: 1
Yuxuan Yao, Ji Dai
Neuroscience Bulletin (2021) Vol. 37, Iss. 8, pp. 1267-1269
Open Access | Times Cited: 1
The adenosine-A2AR-PKA axis in iSPNs: a novel contributor to regulation of locomotion
Zhiwen Yuan, Yong Tang
Purinergic Signalling (2023) Vol. 19, Iss. 2, pp. 379-381
Open Access
Zhiwen Yuan, Yong Tang
Purinergic Signalling (2023) Vol. 19, Iss. 2, pp. 379-381
Open Access